Inflammation and Liver Cell Death in Patients with Hepatitis C Viral Infection

被引:3
|
作者
Neuman, Manuela G. [1 ]
Cohen, Lawrence B. [2 ]
机构
[1] Univ Toronto, In Vitro Drug Safety & Biotechnol, Dept Pharmacol & Toxicol, Temer Fac Med,Banting Inst, 100 Coll St, Toronto, ON M5G 1L5, Canada
[2] Sunnybrook Hlth Sci Ctr, Temer Fac Med, Div Gastroenterol, Dept Med, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
关键词
tumor necrosis factor alpha; apoptosome; inflammasome; cytokines; chemokines; fibrosis; viral hepatitis C; electron microscopy; T-LYMPHOCYTE RESPONSE; INTERFERON RESISTANCE; SUSTAINED RESPONSE; RNA REPLICATION; VIRUS; ALPHA; IDENTIFICATION; ACTIVATION; CYTOKINES; THERAPY;
D O I
10.3390/cimb43030139
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV)-induced liver disease contributes to chronic hepatitis. The immune factors identified in HCV include changes in the innate and adaptive immune system. The inflammatory mediators, known as "inflammasome", are a consequence of the metabolic products of cells and commensal or pathogenic bacteria and viruses. The only effective strategy to prevent disease progression is eradication of the viral infection. Immune cells play a pivotal role during liver inflammation, triggering fibrogenesis. The present paper discusses the potential role of markers in cell death and the inflammatory cascade leading to the severity of liver damage. We aim to present the clinical parameters and laboratory data in a cohort of 88 HCV-infected non-cirrhotic and 25 HCV cirrhotic patients, to determine the characteristic light microscopic (LM) and transmission electron microscopic (TEM) changes in their liver biopsies and to present the link between the severity of liver damage and the serum levels of cytokines and caspases. A matched HCV non-infected cohort was used for the comparison of serum inflammatory markers. We compared the inflammation in HCV individuals with a control group of 280 healthy individuals. We correlated the changes in inflammatory markers in different stages of the disease and the histology. We concluded that the serum levels of cytokine, chemokine, and cleaved caspase markers reveal the inflammatory status in HCV. Based upon the information provided by the changes in biomarkers the clinician can monitor the severity of HCV-induced liver damage. New oral well-tolerated treatment regimens for chronic hepatitis C patients can achieve cure rates of over 90%. Therefore, using the noninvasive biomarkers to monitor the evolution of the liver damage is an effective personalized medicine procedure to establish the severity of liver injury and its repair.
引用
收藏
页码:2022 / 2035
页数:14
相关论文
共 50 条
  • [1] Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection
    Hayashi, J
    Kishihara, Y
    Yamaji, K
    Furusyo, N
    Yamamoto, T
    Pae, Y
    Etoh, Y
    Ikematsu, H
    Kashiwagi, S
    HEPATOLOGY, 1997, 25 (03) : 697 - 701
  • [2] Hepatitis C viral infection in liver transplantation
    Johnson, MW
    Washburn, WK
    Freeman, RB
    FitzMaurice, SE
    Dienstag, J
    Basgoz, N
    Jenkins, RL
    Cosimi, AB
    ARCHIVES OF SURGERY, 1996, 131 (03) : 284 - 291
  • [3] Liver histology in patients on hemodialysis with chronic hepatitis C viral infection
    Mysorekar, Vijaya V.
    Rao, Saraswathi G.
    Mahadeva, K. C.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2008, 51 (02) : 182 - 185
  • [4] Hepatitis C viral infection in liver transplantation - Discussion
    Thompson, W
    Johnson, MW
    ARCHIVES OF SURGERY, 1996, 131 (03) : 291 - 291
  • [5] Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection
    Koike, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 : 82 - 88
  • [6] Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection
    Kazuhiko Koike
    Journal of Gastroenterology, 2009, 44 : 82 - 88
  • [7] Histopathology of the liver in children with chronic hepatitis C viral infection
    Badizadegan, K
    Jonas, MM
    Ott, MJ
    Nelson, SP
    Perez-Atayde, AR
    HEPATOLOGY, 1998, 28 (05) : 1416 - 1423
  • [8] Lipid Metabolism and Liver Disease in Hepatitis C Viral Infection
    Koike, Kazuhiko
    Tsutsumi, Takeya
    Yotsuyanagi, Hiroshi
    Moriya, Kyoji
    ONCOLOGY, 2010, 78 : 24 - 30
  • [9] Hepatitis C (HCV) viral infection alters phenotype and function of liver dendritic cell (LDCS)
    Lai, WK
    Goddard, S
    Curbishley, S
    Youster, J
    Shaw, J
    Adams, DH
    JOURNAL OF HEPATOLOGY, 2005, 42 : 161 - 162
  • [10] Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection
    Cheng, CH
    Huang, CC
    Leu, ML
    Chiang, CYF
    Wu, MS
    Lai, PC
    VACCINE, 1997, 15 (12-13) : 1353 - 1357